|
Apr 14
|
Is Viatris Inc. (VTRS) The Top Healthcare Stock to Buy According to Billionaire David Einhorn?
|
|
Apr 14
|
Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer
|
|
Apr 11
|
Viatris Inc. (VTRS): Among the High-Dividend Stocks to Invest In Under $10
|
|
Apr 10
|
3 Hated Stocks with Mounting Challenges
|
|
Mar 13
|
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks
|
|
Mar 11
|
1 Healthcare Stock to Target This Week and 2 to Turn Down
|
|
Feb 24
|
What's in Store for These 5 Biotech Stocks This Earnings Season?
|
|
Feb 24
|
Stay Ahead of the Game With Viatris (VTRS) Q4 Earnings: Wall Street's Insights on Key Metrics
|
|
Feb 21
|
What's in the Cards for Viatris Stock This Q4 Earnings?
|
|
Feb 21
|
Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks
|
|
Feb 20
|
Earnings Preview: Viatris (VTRS) Q4 Earnings Expected to Decline
|
|
Feb 19
|
Uniting Against AMR: Global Solutions Need Local and Global Collaboration
|
|
Feb 19
|
Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest
|
|
Feb 18
|
3 Reasons to Sell VTRS and 1 Stock to Buy Instead
|
|
Feb 17
|
50 Years of Service: From Milkman's Son to Advancing Access to Medicines
|
|
Feb 14
|
Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks
|
|
Feb 13
|
ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group
|
|
Oct 1
|
Is Viatris Inc. (VTRS) the Best Stock Under $15 To Buy Now?
|
|
Sep 30
|
Viatris launches (Pr)Viagra® ODF in Canada: a new oral dissolving film form of the erectile dysfunction treatment
|
|
Sep 12
|
Viatris 2023 Sustainability Report: Advocating for Patients
|